107 related articles for article (PubMed ID: 34850606)
1. Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2.
Hijikata A; Shionyu-Mitsuyama C; Nakae S; Shionyu M; Ota M; Kanaya S; Hirokawa T; Nakajima S; Watashi K; Shirai T
FEBS Open Bio; 2022 Jan; 12(1):285-294. PubMed ID: 34850606
[TBL] [Abstract][Full Text] [Related]
2. Modulation of
Khadilkar A; Bunch ZL; Wagoner J; Ravindran V; Oda JM; Vidar WS; Clark TN; Manwill PK; Todd DA; Barr SA; Olinger LK; Fink SL; Strangman WK; Linington RG; MacMillan JB; Cech NB; Polyak SJ
J Nat Prod; 2023 Apr; 86(4):1061-1073. PubMed ID: 37043739
[TBL] [Abstract][Full Text] [Related]
3. In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis.
Puttaswamy H; Gowtham HG; Ojha MD; Yadav A; Choudhir G; Raguraman V; Kongkham B; Selvaraju K; Shareef S; Gehlot P; Ahamed F; Chauhan L
Sci Rep; 2020 Nov; 10(1):20584. PubMed ID: 33239694
[TBL] [Abstract][Full Text] [Related]
4. Entrectinib-A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells.
Peralta-Garcia A; Torrens-Fontanals M; Stepniewski TM; Grau-Expósito J; Perea D; Ayinampudi V; Waldhoer M; Zimmermann M; Buzón MJ; Genescà M; Selent J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948390
[TBL] [Abstract][Full Text] [Related]
5. Bepridil is potent against SARS-CoV-2 in vitro.
Vatansever EC; Yang KS; Drelich AK; Kratch KC; Cho CC; Kempaiah KR; Hsu JC; Mellott DM; Xu S; Tseng CK; Liu WR
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33597253
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights.
Marques-Pereira C; Pires MN; Gouveia RP; Pereira NN; Caniceiro AB; Rosário-Ferreira N; Moreira IS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328409
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets.
Alsulami AF; Thomas SE; Jamasb AR; Beaudoin CA; Moghul I; Bannerman B; Copoiu L; Vedithi SC; Torres P; Blundell TL
Brief Bioinform; 2021 Mar; 22(2):769-780. PubMed ID: 33416848
[TBL] [Abstract][Full Text] [Related]
8. Throat spray formulated with virucidal pharmaceutical excipients as an effective early prophylactic or treatment strategy against pharyngitis post-exposure to SARS-CoV-2.
Boseila AA; Ghareeb AZ; AbdElwahab MG; Seadawy MG; Al-Karmalawy AA; Yassa NW; Ghareeb DA
Eur J Pharm Biopharm; 2024 Jun; 199():114279. PubMed ID: 38588829
[TBL] [Abstract][Full Text] [Related]
9. Research progress on pharmacological effects and mechanisms of cepharanthine and its derivatives.
Shi L; Wang S; Zhang S; Wang J; Chen Y; Li Y; Liu Z; Zhao S; Wei B; Zhang L
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2843-2860. PubMed ID: 37338575
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19.
Oh KK; Adnan M; Cho DH
Sci Rep; 2021 May; 11(1):9606. PubMed ID: 33953223
[TBL] [Abstract][Full Text] [Related]
11. Cepharanthine: A Promising Old Drug against SARS-CoV-2.
Fan H; He ST; Han P; Hong B; Liu K; Li M; Wang S; Tong Y
Adv Biol (Weinh); 2022 Dec; 6(12):e2200148. PubMed ID: 35775953
[TBL] [Abstract][Full Text] [Related]
12. Lineage-Specific CYP80 Expansion and Benzylisoquinoline Alkaloid Diversity in Early-Diverging Eudicots.
An Z; Gao R; Chen S; Tian Y; Li Q; Tian L; Zhang W; Kong L; Zheng B; Hao L; Xin T; Yao H; Wang Y; Song W; Hua X; Liu C; Song J; Fan H; Sun W; Chen S; Xu Z
Adv Sci (Weinh); 2024 May; 11(19):e2309990. PubMed ID: 38477432
[TBL] [Abstract][Full Text] [Related]
13. An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor.
Ahmad I; Fatemi SN; Ghaheri M; Rezvani A; Khezri DA; Natami M; Yasamineh S; Gholizadeh O; Bahmanyar Z
Cell Commun Signal; 2023 Dec; 21(1):352. PubMed ID: 38098077
[TBL] [Abstract][Full Text] [Related]
14. Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets.
He Z; Yuan J; Zhang Y; Li R; Mo M; Wang Y; Ti H
Pharm Biol; 2023 Dec; 61(1):1186-1210. PubMed ID: 37605622
[TBL] [Abstract][Full Text] [Related]
15. The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19.
Xia B; Zheng L; Li Y; Sun W; Liu Y; Li L; Pang J; Chen J; Li J; Cheng H
Front Pharmacol; 2023; 14():1098972. PubMed ID: 37583901
[TBL] [Abstract][Full Text] [Related]
16. Development of novel SARS-CoV-2 viral vectors.
Liu H; Liu D
Sci Rep; 2023 Aug; 13(1):13053. PubMed ID: 37567900
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Activity of Cepharanthine.
Liu K; Hong B; Wang S; Lou F; You Y; Hu R; Shafqat A; Fan H; Tong Y
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446681
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.
Rafiq A; Jabeen T; Aslam S; Ahmad M; Ashfaq UA; Mohsin NUA; Zaki MEA; Al-Hussain SA
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375415
[TBL] [Abstract][Full Text] [Related]
19. Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury.
Liang D; Wang W; Chen G; Li J; Dou G; Gan H; Han P; Du L; Gu R
Molecules; 2023 May; 28(11):. PubMed ID: 37298919
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
